Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability
- PMID: 7830109
Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability
Abstract
Twenty consecutive patients were evaluated for presumptive myocardial viability using rest TI-SPECT, FDG-PET and FDG-SPECT. The FDG studies were performed after rest TI-SPECT to guide intervention or medical management.
Methods: Twenty patients with proven coronary artery disease, either known or suspected to have previous myocardial infarction and persistent perfusion defects shown by rest reinjection TI-SPECT, underwent FDG-PET and subsequent FDG-SPECT with a three-detector SPECT camera. FDG-PET and SPECT images were compared by five observers to determine if any fixed thallium segments were visualized by either FDG imaging method.
Results: Thirteen of 60 fixed segments were shown probably viable by FDG-SPECT (8 of 20 patients) and 14 of 60 by FDG PET (7 of 20 patients). Two patients had fixed thallium segments found probably viable with FDG by SPECT alone and one by PET alone.
Conclusion: FDG is shown to provide additional information about myocardial viability. Both SPECT, using a three-detector camera, and PET with a specialized instrument are equally effective for imaging FDG in this application.
Similar articles
-
Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.Circulation. 1991 Jan;83(1):26-37. doi: 10.1161/01.cir.83.1.26. Circulation. 1991. PMID: 1984883 Clinical Trial.
-
Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.J Nucl Med. 1996 Oct;37(10):1631-6. J Nucl Med. 1996. PMID: 8862297
-
Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.J Nucl Med. 1997 Apr;38(4):582-6. J Nucl Med. 1997. PMID: 9098206
-
Present assessment of myocardial viability by nuclear imaging.Semin Nucl Med. 1996 Oct;26(4):315-35. doi: 10.1016/s0001-2998(96)80007-9. Semin Nucl Med. 1996. PMID: 8916320 Review.
-
Myocardial F-18 fluorodeoxyglucose imaging by SPECT.Clin Nucl Med. 1995 Jun;20(6):486-90. doi: 10.1097/00003072-199506000-00002. Clin Nucl Med. 1995. PMID: 7648727 Review.
Cited by
-
Fluorine 18-labeled fluorodeoxyglucose myocardial scintigraphy with Anger gamma cameras for assessing myocardial viability.J Nucl Cardiol. 1995 Jul-Aug;2(4):360-5. doi: 10.1016/s1071-3581(05)80083-2. J Nucl Cardiol. 1995. PMID: 9420813 Review. No abstract available.
-
In vivo label-free optical monitoring of structural and metabolic remodeling of myocardium following infarction.Biomed Opt Express. 2019 Jun 21;10(7):3506-3521. doi: 10.1364/BOE.10.003506. eCollection 2019 Jul 1. Biomed Opt Express. 2019. PMID: 31360603 Free PMC article.
-
Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):972-9. doi: 10.1007/s00259-005-1785-0. Epub 2005 Apr 12. Eur J Nucl Med Mol Imaging. 2005. PMID: 15824927 Clinical Trial.
-
Imaging myocardial metabolic remodeling.J Nucl Med. 2010 May 1;51 Suppl 1(Suppl 1):88S-101S. doi: 10.2967/jnumed.109.068197. J Nucl Med. 2010. PMID: 20457796 Free PMC article. Review.
-
Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure.Curr Cardiol Rep. 2003 Jan;5(1):32-9. doi: 10.1007/s11886-003-0035-y. Curr Cardiol Rep. 2003. PMID: 12493158 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources